Prelude Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,710
| Closed | -$29.7K | – | 1369 |
|
|
2025
Q1 | $29.7K | Sell |
18,710
-800
| -4% | -$1.27K | ﹤0.01% | 1028 |
|
|
2024
Q4 | $59.1K | Buy |
19,510
+4,300
| +28% | +$13K | ﹤0.01% | 1009 |
|
|
2024
Q3 | $56K | Buy |
+15,210
| New | +$56K | ﹤0.01% | 1102 |
|
|
2023
Q4 | – | Sell |
-10,190
| Closed | -$204K | – | 1286 |
|
|
2023
Q3 | $204K | Buy |
10,190
+173
| +2% | +$3.47K | 0.01% | 751 |
|
|
2023
Q2 | $283K | Buy |
+10,017
| New | +$283K | 0.02% | 583 |
|